RSV in Infants: Maternal Vaccine vs. Antibodies (Nirsevimab / Clesrovimab)
Introduction Respiratory syncytial virus (RSV) remains one of the most common and dangerous respiratory infections in early infancy. Nearly every child encounters RSV by the age of two, but for newborns and young babies, especially those under six months, the infection can cause severe bronchiolitis or pneumonia and lead to hospitalization. Each RSV season, which […]
RSV in Infants: Maternal Vaccine vs. Antibodies (Nirsevimab / Clesrovimab) Read More »